John Libbey Eurotext

European Journal of Dermatology


Erythematous cutaneous macules: an uncommon, challenging presentation of T-lymphoblastic lymphoma Article à paraître


  • Figure 1
1 Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia
2 Surgical Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia
3 Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena
4 Hematology Unit, CREO, Azienda Ospedaliera di Perugia, University of Perugia, Perugia
5 Pathology Unit, Azienda Ospedaliero-Universitaria - Ospedali Riuniti di Foggia, Foggia
6 Pathology Unit, Azienda Ospedaliera S. Maria di Terni, University of Perugia, Terni
* Corresponding Author: Maurizio Zizzo, Surgical Oncology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Arcispedale Santa Maria Nuova di Reggio Emilia, Viale Risorgimento, 80, 42123 Reggio Emilia, Italy.

Lymphoblastic lymphoma (LBL) is a neoplasm of precursor B- or T-lymphoid cells [1]. Cutaneous involvement is more commonly associated with B-LBL and often secondary to bone marrow involvement [2]. Primary cutaneous B-LBL with no other sites of disease at presentation is rare [2, 3]. B-LBL affects children or young adults. Skin lesions are usually solitary tumours of the head and neck [2, 3]. In B-LBL, skin lesions can also be the first manifestation of disease recurrence [2]. In T-LBL, cutaneous [...]